Found 8 results
Author Title [ Type(Desc)] Year
Filters: Author is Kim, Jerome H  [Clear All Filters]
Journal Article
P. Pitisuttithum, Rerks-Ngarm, S., Stablein, D., Dawson, P., Nitayaphan, S., Kaewkungwal, J., Michael, N. L., Kim, J. H., Robb, M. L., O'Connell, R. J., Yoon, I. - K., Fernandez, S., and Excler, J. - L., Accuracy of Clinical Diagnosis of Dengue Episodes in the RV144 HIV Vaccine Efficacy Trial in Thailand., PLoS One, vol. 10, no. 5, p. e0127998, 2015.
M. L. Robb, Eller, L. A., Kibuuka, H., Rono, K., Maganga, L., Nitayaphan, S., Kroon, E., Sawe, F. K., Sinei, S., Sriplienchan, S., Jagodzinski, L. L., Malia, J., Manak, M., de Souza, M. S., Tovanabutra, S., Sanders-Buell, E., Rolland, M., Dorsey-Spitz, J., Eller, M. A., Milazzo, M., Li, Q., Lewandowski, A., Wu, H., Swann, E., O'Connell, R. J., Peel, S., Dawson, P., Kim, J. H., and Michael, N. L., Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand., N Engl J Med, vol. 374, no. 22, pp. 2120-30, 2016.
M. L. Robb, Rerks-Ngarm, S., Nitayaphan, S., Pitisuttithum, P., Kaewkungwal, J., Kunasol, P., Khamboonruang, C., Thongcharoen, P., Morgan, P., Benenson, M., Paris, R. M., Chiu, J., Adams, E., Francis, D., Gurunathan, S., Tartaglia, J., Gilbert, P., Stablein, D., Michael, N. L., and Kim, J. H., Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144., Lancet Infect Dis, vol. 12, no. 7, pp. 531-7, 2012.
P. Pitisuttithum, Rerks-Ngarm, S., Bussaratid, V., Dhitavat, J., Maekanantawat, W., Pungpak, S., Suntharasamai, P., Vanijanonta, S., Nitayapan, S., Kaewkungwal, J., Benenson, M., Morgan, P., O'Connell, R. J., Berenberg, J., Gurunathan, S., Francis, D. P., Paris, R., Chiu, J., Stablein, D., Michael, N. L., Excler, J. - L., Robb, M. L., and Kim, J. H., Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in Thailand., PLoS One, vol. 6, no. 12, p. e27837, 2011.
P. B. Gilbert, Berger, J. O., Stablein, D., Becker, S., Essex, M., Hammer, S. M., Kim, J. H., and Degruttola, V. G., Statistical interpretation of the RV144 HIV vaccine efficacy trial in Thailand: a case study for statistical issues in efficacy trials., J Infect Dis, vol. 203, no. 7, pp. 969-75, 2011.
M. S. de Souza, Ratto-Kim, S., Chuenarom, W., Schuetz, A., Chantakulkij, S., Nuntapinit, B., Valencia-Micolta, A., Thelian, D., Nitayaphan, S., Pitisuttithum, P., Paris, R. M., Kaewkungwal, J., Michael, N. L., Rerks-Ngarm, S., Mathieson, B., Marovich, M., Currier, J. R., and Kim, J. H., The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope., J Immunol, vol. 188, no. 10, pp. 5166-76, 2012.
S. Rerks-Ngarm, Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., Premsri, N., Namwat, C., de Souza, M., Adams, E., Benenson, M., Gurunathan, S., Tartaglia, J., McNeil, J. G., Francis, D. P., Stablein, D., Birx, D. L., Chunsuttiwat, S., Khamboonruang, C., Thongcharoen, P., Robb, M. L., Michael, N. L., Kunasol, P., and Kim, J. H., Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand., N Engl J Med, vol. 361, no. 23, pp. 2209-20, 2009.
D. H. Barouch, Liu, J., Li, H., Maxfield, L. F., Abbink, P., Lynch, D. M., M Iampietro, J., SanMiguel, A., Seaman, M. S., Ferrari, G., Forthal, D. N., Ourmanov, I., Hirsch, V. M., Carville, A., Mansfield, K. G., Stablein, D., Pau, M. G., Schuitemaker, H., Sadoff, J. C., Billings, E. A., Rao, M., Robb, M. L., Kim, J. H., Marovich, M. A., Goudsmit, J., and Michael, N. L., Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys., Nature, vol. 482, no. 7383, pp. 89-93, 2012.